20. Kayentao K, Doumbo OK, Penali LK, Offianan AT, Bhatt KM, Kimani J, et al. Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial. Malar J. 2012 Oct 31;11:364. doi: 10.1186/1475-2875-11-364.
19. Coulibaly SO, Kayentao K, Taylor S, Guirou EA, Khairallah C, Guindo N, et al. Parasite clearance following treatment with sulphadoxine-pyrimethamine for intermittent preventive treatment in Burkina-Faso and Mali: 42-day in vivo follow-up study. Malar J. 2014 Jan 31;13:41. doi: 10.1186/1475-2875-13-41.
18. Scott S, Mens PF, Tinto H, Nahum A, Ruizendaal E, Pagnoni F, et al. Community- based scheduled screening and treatment of malaria in pregnancy for improved maternal and infant health in The Gambia, Burkina Faso and Benin: study protocol for a randomized controlled trial. Trials. 2014 Aug 28;15:340. doi: 10.1186/1745-6215-15-340.
17. Gonzalez R, Munguambe K, Aponte J, Bavo C, Nhalungo D, Macete E, et al. High HIV prevalence in a southern semi-rural area of Mozambique: a community-based survey. HIV Med. 2012 Nov;13(10):581-8. doi: 10.1111/j.1468-1293.2012.01018.x.
16. Mwesigwa J, Okebe J, Affara M, Di Tanna GL, Nwakanma D, Janha O, et al. On-going malaria transmission in The Gambia despite high coverage of control interventions: a nationwide cross-sectional survey. Malar J. 2015 Aug 14;14:314. doi: 10.1186/s12936- 015-0829-6.
15. CPMP. Committee for Proprietary Medicinal Products (CPMP) (2000) “Points to consider on switching between superiority and noninferiority” The European Agency for the Evaluation of Medicinal Products, London. 2000.
14. Snappin S. Noninferiority trials. Curr Controll Trials in Cardiovasc Med 2000; 1:19- 21. 2000. DOI: 10.1186/cvm-1-1-019
13. Manyando C, Kayentao K, D’Alessandro U, Okafor HU, Juma E, Hamed K. A systematic review of the safety and efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria during pregnancy. Malar J. 2012 May 01;11:141. doi: 10.1186/1475-2875-11-141
12. Baiden R, Oduro A, Halidou T, Gyapong M, Sie A, Macete E, et al. Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim(R) (dihydroartemisinin/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and Tanzania. Malar J. 2015 Apr 15;14:160. doi: 10.1186/s12936-015-0664-9.
11. D’Alessandro U. Existing antimalarial agents and malaria-treatment strategies. Expert Opin Pharmacother. 2009 Jun;10(8):1291-306. doi: 10.1517/14656560902942319.